Group leader co-founds protein-engineering company to transform regenerative medicine
News / 16 November 2023
EMBL Australia group leader Mikaël Martino has co-founded protein-engineering company Orio Therapeutics.
News / 16 November 2023
EMBL Australia group leader Mikaël Martino has co-founded protein-engineering company Orio Therapeutics.
News / 3 November 2023
On a recent visit to EMBL Heidelberg, Ian Smith, Chair of the EMBL Australia Council, spoke about the synergies between EMBL and EMBL Australia, opportunities for collaboration and ideas for exciting future programs.
News / 2 November 2023
Michelle Boyle – an EMBL Australia group leader and Snow Medical Fellow based at the Burnet Institute – and Burnet Institute CEO and Director Brendan Crabb share their thoughts on the malaria vaccine newly recommended by the World Health Organisation in an article for The Conversation.
News / 30 October 2023
Newsletters / 26 September 2023
News this quarter:
And more:
News / 22 September 2023
Dr Qi Zhang will commence in December as the first EMBL Australia Group Leader to be based at the South Australian immunoGENomics Cancer Institute (SAiGENCI), Adelaide.
News / 15 September 2023
A study co-led by group leader Dr Senthil Arumugam and published in Nature Communications reveals a novel mechanism by which cells control the orderly & timely delivery of molecular cargo.
News / 14 September 2023
We’re excited to announce that Dr Qi Zhang will be the first EMBL Australia group leader to be hosted at the South Australian immunoGENomics Cancer Institute.
Newsletters / 6 June 2023
News this quarter:
And more:
News / 6 June 2023
EMBL Australia researchers have made an exciting breakthrough in the field of regenerative medicine, offering new hope for safer and more effective treatments.
Keep up to date with all the latest EMBL Australia news and events.